WuXi AppTec Co., Ltd. (SHA:603259)

Market Cap	149.57B
Revenue (ttm)	37.92B
Net Income (ttm)	9.45B
Shares Out	2.89B
EPS (ttm)	2.73
PE Ratio	16.06
Forward PE	13.27
Dividend	0.98 (1.87%)
Ex-Dividend Date	Jun 26, 2024

Volume	21,868,537
Average Volume	50,798,161
Open	51.98
Previous Close	52.36
Day's Range	51.82 - 52.59
52-Week Range	36.36 - 70.68
Beta	0.87
RSI	31.48
Earnings Date	Apr 28, 2025

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally. The company operates in six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2000
• Employees: 39,414
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603259

Financial Performance

In 2024, WuXi AppTec's revenue was 37.92 billion, a decrease of -1.97% compared to the previous year's 38.68 billion. Earnings were 9.45 billion, a decrease of -1.63%.